Catalyst
Slingshot members are tracking this event:
Editas Medicine Announces Initial Public Offering of 5,900,000 shares at a public offering price of $16.00 per share; trading expected to begin on Wednesday, February 3, 2016 under the ticker symbol “EDIT.”
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EDIT |
|
|
||||
Additional Information
In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 885,000 shares of common stock from Editas Medicine at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 03, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Initial Public Offering
